Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Pål-Ørjan Johansen"'
Autor:
Teri S Krebs, Pål-Ørjan Johansen
Publikováno v:
F1000Research, Vol 2 (2013)
We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. The
Externí odkaz:
https://doaj.org/article/971dba8f137a472eb4abd38e77069f84
Autor:
Teri S Krebs, Pål-Ørjan Johansen
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e63972 (2013)
The classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelics have been
Externí odkaz:
https://doaj.org/article/06ce5af0f8064ef3a421a7b23c4a8617
Publikováno v:
Journal of Psychopharmacology. 29:1035-1040
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fce9e0554decd160f9d586067dd7ab
https://doi.org/10.1177/0269881115596156
https://doi.org/10.1177/0269881115596156
Autor:
John S. Martin-Joy, Xing-jia Cui, George E. Vaillant, Robert J. Waldinger, Pål-Ørjan Johansen, Johanna C. Malone, M. Omar Rahman, Kevin P. Hill
Publikováno v:
The Journal of nervous and mental disease. 205(9)
The present study examines changes in defense maturity from mid to late life using data from an over 70-year longitudinal study. A sample of 72 men was followed beginning in late adolescence. Participants' childhoods were coded for emotional warmth.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09b3e64b53301853ce7e0dbc64b8f6e
https://pubmed.ncbi.nlm.nih.gov/28682982
https://pubmed.ncbi.nlm.nih.gov/28682982
Publikováno v:
Journal of psychopharmacology (Oxford, England). 29(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cfa75a0fd7e72a92b80c028196480e5f
https://pubmed.ncbi.nlm.nih.gov/26395581
https://pubmed.ncbi.nlm.nih.gov/26395581
Autor:
Teri Suzanne Krebs, Pål-Ørjan Johansen
Publikováno v:
Journal of psychopharmacology (Oxford, England). 29(3)
A recent large population study of 130,000 adults in the United States failed to find evidence for a link between psychedelic use (lysergic acid diethylamide, psilocybin or mescaline) and mental health problems. Using a new data set consisting of 135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022961ada0000e5818fdcac016bd9ac5
https://pubmed.ncbi.nlm.nih.gov/26649373
https://pubmed.ncbi.nlm.nih.gov/26649373
Autor:
Teri Suzanne Krebs, Pål-Ørjan Johansen
Publikováno v:
Journal of Psychopharmacology. 23:389-391
Abstract Exposure therapy is known to be an effective treatment for anxiety disorders. Nevertheless, exposure is not used as much as it should be, and instead patients are often given supportive medications such as serotonin reuptake inhibitors (SSRI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1ee9392af2dd43fb42cacad28c463c
https://doi.org/10.1177/0269881109102787
https://doi.org/10.1177/0269881109102787
Autor:
Pål-Ørjan Johansen, Teri Suzanne Krebs
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e63972 (2013)
PLOS ONE
PLoS ONE, Vol 8, Iss 8, p e63972 (2013)
PLOS ONE
Background The classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c33788899b843419bb6da0ee23f1c7
http://europepmc.org/articles/PMC3747247
http://europepmc.org/articles/PMC3747247
Autor:
Pål-Ørjan Johansen, Teri Suzanne Krebs
Publikováno v:
F1000Research
We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02db0ce6235cd38b7c73994c41f9a671
https://pubmed.ncbi.nlm.nih.gov/24627778
https://pubmed.ncbi.nlm.nih.gov/24627778
Autor:
Teri Suzanne Krebs, Pål Ørjan Johansen
Publikováno v:
Journal of psychopharmacology (Oxford, England). 26(7)
Assessments of lysergic acid diethylamide (LSD) in the treatment of alcoholism have not been based on quantitative meta-analysis. Hence, we performed a meta-analysis of randomized controlled trials in order to evaluate the clinical efficacy of LSD in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d9472ab0f05ad1d5caa4b1b076dd31
https://pubmed.ncbi.nlm.nih.gov/22406913
https://pubmed.ncbi.nlm.nih.gov/22406913